Table of Contents
Washington University Experience | NEOPLASMS (HEMATOLYMPHOID) | Lymphoma, secondary | 6C2 Lymphoma, secondary (Case 6) CD79a.jpg
Immunohistochemically stained sections show strong reactivity within tumor cells for the B-cell marker CD79A.
